Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Orthopediatrics (KIDS) Beginning Cash Balance (2020 - 2022)

Orthopediatrics has reported Beginning Cash Balance over the past 2 years, most recently at $27.8 million for Q3 2022.

For Q3 2022, Beginning Cash Balance changed N/A year-over-year to $27.8 million; the TTM value through Dec 2023 reached $27.8 million, changed 0.0%, while the annual FY2022 figure was $31.0 million, N/A changed from the prior year.
Beginning Cash Balance for Q3 2022 was $27.8 million at Orthopediatrics, up from $20.0 million in the prior quarter.
Over five years, Beginning Cash Balance peaked at $27.8 million in Q3 2022 and troughed at $5.0 million in Q1 2020.